Compare RDHL & GXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RDHL | GXAI |
|---|---|---|
| Founded | 2009 | 2021 |
| Country | Israel | United States |
| Employees | N/A | 3 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6M | 11.7M |
| IPO Year | 2012 | 2022 |
| Metric | RDHL | GXAI |
|---|---|---|
| Price | $0.88 | $1.32 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 27.5K | ★ 9.0M |
| Earning Date | 04-09-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 71.35 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,933,030.00 |
| Revenue This Year | $381.91 | $42,959.35 |
| Revenue Next Year | N/A | $100.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 47901.74 |
| 52 Week Low | $0.80 | $1.00 |
| 52 Week High | $3.31 | $2.96 |
| Indicator | RDHL | GXAI |
|---|---|---|
| Relative Strength Index (RSI) | 38.10 | 48.44 |
| Support Level | $0.80 | $1.11 |
| Resistance Level | $1.07 | $1.38 |
| Average True Range (ATR) | 0.05 | 0.18 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 35.29 | 11.51 |
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.
Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.